Danziger Asaf
SEC insider (Form 3/4/5 filer). CIK 0001654435. Director at NovoCure Ltd (NVCR). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in WAYNE, PA.
Companies Danziger Asaf has filed insider reports for
- NovoCure Ltd (NVCR): Director
Danziger Asaf
CIK: 0001654435
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)5 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NVCR
NovoCure Ltd
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 30, 2026NVCR
NovoCure Ltd
AwardDirect268 shares at avg. $11.15$3K - Dec 31, 2025NVCR
NovoCure Ltd
AwardDirect1 shares at avg. $10.99$10.99 - Jun 30, 2025NVCR
NovoCure Ltd
AwardDirect833 shares at avg. $15.13$13K - Jan 1, 2025NVCR
NovoCure Ltd
AwardDirect400K shares- - Dec 31, 2024NVCR
NovoCure Ltd
AwardDirect412 shares at avg. $14.75$6K
1-5 of 5 transactions